These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27881006)

  • 1. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.
    He L; Deng HY; C Wang X
    Neoplasma; 2017; 64(1):65-73. PubMed ID: 27881006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
    Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O
    Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.
    Koslowski M; Türeci O; Huber C; Sahin U
    Mol Cancer; 2009 Sep; 8():77. PubMed ID: 19781065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
    Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
    J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.
    Qi L; Ding Y
    Cell Physiol Biochem; 2018; 46(6):2543-2550. PubMed ID: 29742509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
    Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
    J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derlin-1 is overexpressed in human colon cancer and promotes cancer cell proliferation.
    Tan X; He X; Jiang Z; Wang X; Ma L; Liu L; Wang X; Fan Z; Su D
    Mol Cell Biochem; 2015 Oct; 408(1-2):205-13. PubMed ID: 26173415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patients.
    Dekervel J; Hompes D; van Malenstein H; Popovic D; Sagaert X; De Moor B; Van Cutsem E; D'Hoore A; Verslype C; van Pelt J
    Clin Cancer Res; 2014 Apr; 20(8):2159-68. PubMed ID: 24486594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity.
    Barbáchano A; Ordóñez-Morán P; García JM; Sánchez A; Pereira F; Larriba MJ; Martínez N; Hernández J; Landolfi S; Bonilla F; Pálmer HG; Rojas JM; Muñoz A
    Oncogene; 2010 Aug; 29(34):4800-13. PubMed ID: 20543868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
    Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
    Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro.
    Che XH; Chen CL; Ye XL; Weng GB; Guo XZ; Yu WY; Tao J; Chen YC; Chen X
    Oncol Rep; 2016 Mar; 35(3):1680-8. PubMed ID: 26707712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.
    Aleman MJ; DeYoung MP; Tress M; Keating P; Perry GW; Narayanan R
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12765-70. PubMed ID: 16129820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.
    Zhang M; Cui F; Lu S; Lu H; Xue Y; Wang J; Chen J; Zhao S; Ma S; Zhang Y; Yu Y; Peng Z; Tang H
    J Exp Clin Cancer Res; 2015 Jun; 34(1):60. PubMed ID: 26063247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.